Raia Drogasil SA banner

Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 22.31 BRL 1.18% Market Closed
Market Cap: R$39.1B

Raia Drogasil SA
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Raia Drogasil SA
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Raia Drogasil SA
BOVESPA:RADL3
Income from Continuing Operations
R$1.3B
CAGR 3-Years
9%
CAGR 5-Years
21%
CAGR 10-Years
14%
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
Income from Continuing Operations
R$260.9m
CAGR 3-Years
0%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Income from Continuing Operations
R$124.6m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
11%
d
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Income from Continuing Operations
R$22.6m
CAGR 3-Years
26%
CAGR 5-Years
184%
CAGR 10-Years
N/A
No Stocks Found

Raia Drogasil SA
Glance View

Market Cap
39.1B BRL
Industry
Retail

Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.

RADL3 Intrinsic Value
18.1 BRL
Overvaluation 19%
Intrinsic Value
Price R$22.31

See Also

What is Raia Drogasil SA's Income from Continuing Operations?
Income from Continuing Operations
1.3B BRL

Based on the financial report for Dec 31, 2025, Raia Drogasil SA's Income from Continuing Operations amounts to 1.3B BRL.

What is Raia Drogasil SA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
14%

Over the last year, the Income from Continuing Operations growth was 7%. The average annual Income from Continuing Operations growth rates for Raia Drogasil SA have been 9% over the past three years , 21% over the past five years , and 14% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett